Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Integrated Cervical Cancer Testing Provides Leading-Edge Solutions for New Screening Needs

By LabMedica International staff writers
Posted on 19 Nov 2013
An integrated set of assays and instruments used for cervical cancer testing enables laboratories and physicians to provide high diagnostic accuracy combined with screening efficiency for their patients.

Virtually all known cases of cervical cancer are caused by specific types of human papillomavirus (HPV), with 14 HPV genotypes being considered high-risk (HR) for causing cancer. More...
BD Diagnostics, a segment of Becton, Dickinson and Company (BD; Franklin Lakes, NJ, USA), has announced at EUROGIN 2013 that BD has achieved CE/IVD marking of its “Totalys” MultiProcessor, an automated instrument that integrates the preprocessing for BD’s “SurePath” Liquid-based Pap Test with a molecular aliquot, maintaining sample integrity while improving laboratory efficiency. At the conference, BD also highlighted the performance of its new “Onclarity” HPV Assay on the BD “Viper” LT System, which is pending EU certification.

“These new products are part of BD’s integrated Women's Health portfolio and support full sample chain of custody, high diagnostic accuracy, and a clear patient management approach – all important elements to improving patient care,” said Paul Holt, Global Market Segment Leader, Women’s Health & Cancer, BD Diagnostics.

The Totalys MultiProcessor provides balance of automation and flexibility, streamlining processes and removing inefficiencies. The highly automated sample preparation for cytology and molecular testing helps enhance lab productivity, while random sample loading reduces hands-on time. The system provides remote diagnostic and service capabilities to maintain optimal system uptime.

The Onclarity HPV Assay targets E6/E7 DNA oncogenes and is designed to provide physicians access to broader HPV genotype information to guide informed treatment decisions. The assay reports results on six discrete high-risk HPV genotypes (16, 18, 45, 31, 51, and 52) with the remaining eight HR genotypes reported in three small groups: (33, 58), (35, 39, 68) and (56, 59, 66). HR genotype and genotype group results are obtained from the same sample with no additional processing steps. The Onclarity HPV Assay is designed for the BD Viper LT System, a bench-top instrument that automates sample setup, DNA extraction, RT PCR amplification and detection with minimal lab technician intervention during processing. The Viper LT System’s integrated design and ease-of-use supports adoption in both cytology and molecular laboratory environments. The BD Onclarity HPV Assay is pending EU certification and is expected to be available December 2013 in Europe and Asia (not currently for sale or distribution in the USA).

Related Links:

Becton, Dickinson and Company



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.